ACAD - ACADIA Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart

ACAD is currently covered by 19 analysts with an average potential upside of $8.81 (36.01%) backed by displayed 204 price targets and 275 ratings.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 78.73% with an average time for these price targets to be met of 265.52 days.

Highest price target for ACAD is 32, Lowest price target is 13, average price target is 22.5.

Most recent stock forecast was given by JEFFREY HUNG from MORGAN STANLEY on 03-Aug-2023. First documented stock forecast 19-Mar-2013.

Currently, out of the existing stock ratings of ACAD - 64 which are a Hold (53.33%), 53 which are a Buy (44.17%), 3 which are a Sell (2.5%)

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Hold

30

$4.42 (17.28%)

30

1 months 25 days ago

14/20 (70%)

$6 (20.78%)

165

Buy

38

$12.42 (48.55%)

26

1 months 25 days ago

15/18 (83.33%)

$7.65 (27.96%)

182

Buy

33

$7.42 (29.01%)

33

1 months 25 days ago

9/13 (69.23%)

$8.33 (34.09%)

122

Hold

25

$-0.58 (-2.27%)

25

1 months 25 days ago

10/12 (83.33%)

$-0.47 (0.44%)

40

Buy

33

$7.42 (29.01%)

27

2 months 14 days ago

10/16 (62.5%)

$9.2 (38.05%)

224

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ACAD (ACADIA Pharmaceuticals) average time for price targets to be met?

On average it took 265.52 days on average for the stock forecasts to be realized with a an average price target met ratio 78.73

Which analyst has the current highest performing score on ACAD (ACADIA Pharmaceuticals) with a proven track record?

CORY KASIMOV

Which analyst has the most public recommendations on ACAD (ACADIA Pharmaceuticals)?

Cory Kasimov works at JPMORGAN and has 9 price targets and 5 ratings on ACAD

Which analyst is the currently most bullish on ACAD (ACADIA Pharmaceuticals)?

Alan Carr with highest potential upside - $34.42

Which analyst is the currently most reserved on ACAD (ACADIA Pharmaceuticals)?

Salveen Richter with lowest potential downside - -$13.58

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart